Purchase Order HHSD2002017M94395P
- Not listed
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 INSTRUMENT IVD, with a ceiling value of $90,000.00 and a completion date of July 15, 2017. Roche Diagnostics has received numerous federal contract awards, including through its...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Roche Diagnostics Corporation for the MAGNA PURE 96 IVD INSTRUMENT. The contract has a ceiling value of $105,000.00 and an ultimate completion date of March 21, 2016. The contract is not designated as a set-aside. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for ROCHE MAGNA PURE 96 laboratory equipment. The contract has a ceiling value of $90,000.00 and a completion date of September 29, 2022. Roche Diagnostics has experience as a prime contractor and subcontractor providing medical equipment, reagents, and associated products and services to various federal agencies, including the Department of Veterans Affairs,...
- This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...
- This federal contract award, with an ID of HHSD2002017M93189P, was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the procurement of a MAGNA PURE 96 INSTRUMENT WITH ACCESSORIES. The fixed-price contract has a ceiling value of $105,000.00 and an ultimate completion date of March 30, 2017. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, titled "MAGNA 96", has an ultimate completion date of November 30, 2015 and does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment,...
- This federal contract award, valued at $90,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the delivery of a MAGNA PURE 96 INSTRUMENT and does not have a set-aside designation. Roche Diagnostics has previously received prime contract and subcontract awards from various federal agencies,...
- This is a $109,000.00 firm fixed price purchase order awarded by the Air Education and Training Command, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation for the MAGNA PURE 96 INSTRUMENT. The award did not utilize a set-aside program. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, and has received numerous federal contract awards to supply medical equipment and...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the MAGNA PURE96 INSTRUMENT. The contract has a ceiling value of $91,563.00 and an ultimate completion date of August 31, 2017. The contract is not designated as a set-aside. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies through prime contracts and subcontracts. Roche holds several Indefinite Delivery Contracts and Blanket Purchase Agreements with federal agencies, which streamline their ability to purchase essential medical equipment and consumables.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $91.6k | 6/15/17 |